Lanaken

Researchers are evaluating the Suicidal Crisis Intervention SCI as a new short-term treatment method for people after a suicidal crisis or suicide attempt. This study aims to determine if SCI can reduce suicidality and also explore its effect on related factors such as hopelessness, defeat, entrapment, and interpersonal needs. The SCI was developed to provide evidence-based care in Flanders, addressing the limited interventions currently available for this high-risk group. The study compares two groups one receiving the SCI alongside their usual treatment, and the other receiving only their usual treatment. The SCI includes four sessions focusing on providing insight into suicidal crises, involving loved ones, creating a safety plan, and ensuring continuity of care. It emphasizes a structured, person-centered approach and aims to motivate participants toward specialized care. Participants will be followed for approximately 222 days after randomization. Researchers will assess changes in suicidality using the Beck Scale for Suicide Ideation at multiple points, along with secondary measures such as suicidal behavior, hopelessness, defeat, entrapment, isolation, follow-up care readiness, and treatment satisfaction. Assessments are conducted at baseline, 42 days, 132 days, and 222 days to monitor progress and outcomes throughout the study period.